The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

In 2026, Medicare participants will pay more for their health care. Part B costs are expected to rise more than 10%. Here's ...

Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural ...

A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.

The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...

Trump is changing Medicare, mostly focusing on providers. But the biggest impact may come from tariffs and deporting ...

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...

The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...

Thousands of Rhode Island seniors and disabled residents no longer covered for non-emergency visits at four local hospitals ...

Tens of millions of Americans rely on the programs, and they have protected the country's most vulnerable populations for over six decades now.

Working seniors need professional advice when making coverage decisions, but only 21% of retirees with advisers receive ...

The U.S. Government Accountability Office (GAO) says that steps are being taken to address healthcare fraud. For one thing, ...